Frontiers in Clinical Neuroscience Plenary Session Focuses on Translational Research

March 12, 2009

Share:

Four noted physician-scientists will outline their recent research findings, along with the clinical implications of their work, at the Frontiers in Clinical Neuroscience Plenary Session on Thursday, April 30, from 9:00 a.m. to 11:00 a.m. in the Washington State Convention and Trade Center. The session, moderated by John W. Griffin, MD, Lecture Awards Subcommittee Chair, is open to all Annual Meeting participants.

Helen S. Mayberg, MD, Professor of Psychiatry and Behavioral Sciences and Neurology and the Dorothy C. Fuqua Chair in Psychiatric Imaging and Therapeutics at the Emory University School of Medicine, will discuss "Modulating Putative Depression Circuits Using Deep Brain Stimulation." In this presentation, Mayberg describes the development of deep brain stimulation (DBS) as a novel therapy for treatment of resistant depression.

Henry L. Paulson, MD, PhD, FAAN is the Lucile Groff Professor of Neurology in the Department of Neurology at the University of Michigan, where he oversees departmental programs in neurodegenerative diseases. In his presentation, "Toward Therapies for Polyglutamine Diseases," Paulson explores how polyglutamine expansion diseases collectively represent a major cause of heritable neurodegeneration. The discussion will also touch on promising therapeutic strategies for polyglutamine disorders.

Caroline Tanner, MD, PhD, FAAN, has served as the Director of Clinical Research at the Parkinson's Institute in Sunnyvale since 1990. Tanner has been an active member of the AAN since her residency, and is the current chair of the Neuroepidemiology Section of the AAN; she also has served as the chair of the Movement Disorders Section and on the Annual Meeting Scientific Program Subcommittee, among other activities. Tanner's presentation, "Seeking the Causes of Parkinson's Disease," focuses on research indicating that Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases.

Stephen T. Warren, PhD, is currently the William Patterson Timmie Professor of Human Genetics and Chair of the Department of Human Genetics at Emory University School of Medicine, which he founded in 2001. He is also Professor of Biochemistry and Professor of Pediatrics at Emory. Warren's presentation, "Mechanisms of Fragile X Syndrome and Associated Disorders," will observe details related to fragile X syndrome (FXS) as a common inherited form of cognitive impairment and autism.

Read more about the 2009 Scientific Plenary Sessions.